Capital Advisors Wealth Management LLC Purchases Shares of 70,000 Delcath Systems, Inc. (NASDAQ:DCTH)

Capital Advisors Wealth Management LLC acquired a new stake in Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 70,000 shares of the company's stock, valued at approximately $891,000. Capital Advisors Wealth Management LLC owned about 0.21% of Delcath Systems as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of DCTH. Quarry LP bought a new position in Delcath Systems in the fourth quarter valued at about $34,000. Quantbot Technologies LP acquired a new position in Delcath Systems in the fourth quarter valued at about $66,000. Inlight Wealth Management LLC acquired a new position in shares of Delcath Systems during the 1st quarter worth about $85,000. Graham Capital Management L.P. bought a new stake in shares of Delcath Systems in the 4th quarter valued at about $123,000. Finally, NBC Securities Inc. raised its position in shares of Delcath Systems by 99,900.0% in the 1st quarter. NBC Securities Inc. now owns 10,000 shares of the company's stock valued at $127,000 after acquiring an additional 9,990 shares during the period. Institutional investors and hedge funds own 61.12% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on DCTH shares. HC Wainwright reissued a "buy" rating and set a $29.00 price target (up from $24.00) on shares of Delcath Systems in a research report on Friday, May 23rd. Wall Street Zen lowered Delcath Systems from a "strong-buy" rating to a "buy" rating in a research report on Sunday, June 1st. Finally, Stephens restated an "overweight" rating and set a $25.00 target price on shares of Delcath Systems in a report on Monday, June 23rd. Five analysts have rated the stock with a buy rating, According to data from MarketBeat, Delcath Systems presently has an average rating of "Buy" and an average price target of $24.00.

Delcath Systems Stock Down 2.0%

DCTH traded down $0.25 during trading hours on Wednesday, hitting $12.51. 661,452 shares of the company's stock were exchanged, compared to its average volume of 421,275. The stock has a market cap of $435.72 million, a price-to-earnings ratio of -25.02 and a beta of 0.87. Delcath Systems, Inc. has a 1-year low of $7.17 and a 1-year high of $18.23. The stock's 50-day moving average is $14.71 and its two-hundred day moving average is $13.79.

Delcath Systems (NASDAQ:DCTH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.07). Delcath Systems had a negative return on equity of 29.44% and a negative net margin of 26.38%. The company had revenue of $19.80 million for the quarter, compared to the consensus estimate of $16.83 million. On average, equities research analysts anticipate that Delcath Systems, Inc. will post -0.79 EPS for the current year.

Delcath Systems Profile

Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.